[HTML][HTML] Percutaneous coronary intervention in multi-vessel disease
T Akbari, R Al-Lamee - Cardiovascular Revascularization Medicine, 2022 - Elsevier
Coronary disease carries significant morbidity and mortality globally. The pandemic of
obesity and diabetes combined with an aging population have resulted in a significant …
obesity and diabetes combined with an aging population have resulted in a significant …
Complete myocardial revascularization confers a larger clinical benefit when performed with state‐of‐the‐art techniques in high‐risk patients with multivessel coronary …
M Zimarino, F Ricci, M Romanello… - Catheterization and …, 2016 - Wiley Online Library
Objectives To test whether a strategy of complete revascularization (CR) as compared with
incomplete myocardial revascularization (IR)—both performed with current “state‐of‐the‐art” …
incomplete myocardial revascularization (IR)—both performed with current “state‐of‐the‐art” …
Patients with chronic total occlusions undergoing percutaneous coronary interventions: characteristics, success, and outcomes
Background—Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO)
has been identified as a beneficial treatment, but there is limited information about its use in …
has been identified as a beneficial treatment, but there is limited information about its use in …
Impact of incomplete percutaneous revascularization in patients with multivessel coronary artery disease: a systematic review and meta‐analysis
Background Up to half of patients undergoing percutaneous coronary intervention have
multivessel coronary artery disease (MVD) with conflicting data regarding optimal …
multivessel coronary artery disease (MVD) with conflicting data regarding optimal …
Comparison of coronary artery bypass grafting and drug-eluting stents in patients with chronic kidney disease and multivessel disease: a meta-analysis
Y Wang, S Zhu, P Gao, Q Zhang - European journal of internal medicine, 2017 - Elsevier
Background The optimal revascularization strategy of coronary artery bypass grafting
(CABG) versus percutaneous coronary intervention with drug-eluting stent (PCI-DES) in …
(CABG) versus percutaneous coronary intervention with drug-eluting stent (PCI-DES) in …
Association of coronary vessel characteristics with outcome in patients with percutaneous coronary interventions with incomplete revascularization
Importance Many studies have compared outcomes for incomplete revascularization (IR)
among patients undergoing percutaneous coronary interventions (PCI), but little is known …
among patients undergoing percutaneous coronary interventions (PCI), but little is known …
The adequacy of myocardial revascularization in patients with multivessel coronary artery disease
M Zimarino, N Curzen, V Cicchitti… - International journal of …, 2013 - Elsevier
In patients with multi-vessel coronary artery disease (MVCAD) myocardial revascularization
may be accomplished either on all diseased lesions–complete myocardial revascularization …
may be accomplished either on all diseased lesions–complete myocardial revascularization …
Clinical outcomes of patients with multivessel coronary artery disease treated with robot-assisted coronary artery bypass graft surgery versus one-stage percutaneous …
CS Su, CH Shen, KH Chang, CH Lai, TJ Liu, KJ Chen… - Medicine, 2019 - journals.lww.com
A number of studies have reported on treatment outcomes of coronary stenting (PCI) for
multivessel coronary artery diseases (MVD), and compared them with the conventional …
multivessel coronary artery diseases (MVD), and compared them with the conventional …
Complete Versus Incomplete Percutaneous Coronary Intervention-Mediated Revascularization in Patients With Chronic Coronary Syndromes
Multivessel coronary artery disease (CAD) is associated with worse outcomes across the
spectrum of clinical presentations. The prognostic implications of completeness of …
spectrum of clinical presentations. The prognostic implications of completeness of …
Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era
JW Chung, KH Park, MH Lee, KW Park, JS Park… - Circulation …, 2012 - jstage.jst.go.jp
Background: The benefit of complete (CR) vs. incomplete revascularization (IR) with drug-
eluting stent (DES), unlike with bypass grafting, is not well established in patients with …
eluting stent (DES), unlike with bypass grafting, is not well established in patients with …